Drugs News and Research

RSS

Effective AIDS treatment but poor accessibility: Report from International AIDS conference 2010

At the 18th AIDS conference 2010 in Vienna, Julio Montaner — the President of the International AIDS Society and Chairman of the AIDS 2010 conference said this Sunday that the G-8 countries were not doing enough to ensure treatment of all people infected with HIV and AIDS. He said, “This is a very serious deficit… Let's rejoice in the fact that today we have treatments that work ... what we need is the political will to go the extra mile to deliver universal access.”

18 Jul 2010

Artificial colours in food linked to cancer and behavioral disorders in children: Study

Artificial colours in foods, scientists have found may increase the risk of getting cancer, allergies and may trigger hyperactivity in susceptible children. This new report entitled, “Food Dyes: A Rainbow of Risks”, has come from the research conducted by the Centre for Science in the Public Interest (CSPI).

18 Jul 2010

Researchers to receive $1.2M from Susan G. Komen for the Cure for breast cancer research

Four researchers from Detroit, Michigan's Barbara Ann Karmanos Cancer Institute and Wayne State University will receive a total of $1.2 million from Susan G. Komen for the Cure to help advance research to better detect, prevent and eliminate breast cancer. The $1.2 million awarded to these outstanding scientists is part of the $59 million portfolio of research grants that Susan G. Komen for the Cure has awarded this year alone to scientists across the globe to help accelerate innovative breast cancer research.

17 Jul 2010

CCTP focuses on identifying, testing drugs for cancer stem cell treatment

Cancer and stem cell biology researchers at the University of Colorado are launching the nation's first program focused on identifying and testing drugs that target and destroy cells thought to be at the root of cancer-cancer stem cells (CSCs).The Cancer Stem Cell-Directed Clinical Trials Program (CCTP) is a collaboration between the University of Colorado Cancer Center and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine.

17 Jul 2010

Maxygen's option and licensing arrangement with Cangene expires

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.

17 Jul 2010

Ingen files patent to produce new drug insulin thermos product

Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.

17 Jul 2010

NCOA adds ILS as partner to sponsor Private Label version of online screening service for senior benefits

The National Council on Aging (NCOA) today announced the addition of Independent Living Systems (ILS) as the newest partner to sponsor a Private Label version of BenefitsCheckUp, NCOA's online screening service for senior benefits. The Private Label version of BenefitsCheckUp will allow ILS to enhance the care management services the company currently provides to its clients, many of whom are frail and underprivileged individuals who require chronic care or other special needs.

17 Jul 2010

Pain medication abuse soars

The Associated Press: "A new government study finds a 400 percent increase in the number of people admitted to treatment for abusing prescription pain medication. The increase in substance abuse among people ages 12 and older was recorded during the 10-year-period from 1998 to 2008. It spans every gender, race, ethnicity, education and employment level, and all regions of the country" (7/15).

17 Jul 2010

Cleveland Clinic to provide heart care in Chicago; Johns Hopkins increases primary care in D.C. area

Chicago Tribune: "In a move likely to shake up the market for heart care in the Chicago area, the Cleveland Clinic's cardiac surgery program has signed an affiliation agreement with Central DuPage Hospital in west suburban Winfield. The deal, announced Thursday, is designed to enhance the heart care provided at the 313-bed hospital and potentially bring Cleveland Clinic patient referrals at a time when fewer heart surgeries are needed than were a decade ago.

17 Jul 2010

Amgen granted FDA priority review designation for denosumab BLA

Amgen today announced that the U.S. Food and Drug Administration (FDA) has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events (SREs) in patients with cancer.

17 Jul 2010

FDA can promote personalized medicine by identying gaps in laboratory operations: ACLA

The Food and Drug Administration can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way according to the American Clinical Laboratory Association (ACLA). ACLA, which represents the nation's leading clinical laboratories, says that the factors supporting this approach include the growing role that such tests play in clinical decision making, especially in the area of new advanced diagnostics that derive from the mapping of the human genome and help fulfill the promise of personalized medicine.

17 Jul 2010

Capitol Hill Watch: Obama agenda under scrutiny as lawmakers talk Medicare, budgets

President Obama's agenda, which includes a sweeping overhaul of the health care system, is coming under increased political scrutiny as lawmakers struggle with health budget challenges, and consider issues such as medical bankruptcy and improper Medicare payments.

17 Jul 2010

94 indicted in five-state crackdown on Medicare fraud

Law enforcement officers fanned out across five states Friday in what federal officials called the largest Medicare fraud bust ever conducted. Nearly 100 people were indicted in frauds that totaled $251 million.

17 Jul 2010

Research findings may help identify human TOR kinase inhibitors

A parasite estimated to afflict as many as 12 million people worldwide relies on a family of genes that should make it vulnerable to compounds developed to treat cancer and other disorders, researchers at Washington University School of Medicine in St. Louis have found.

17 Jul 2010

Recent releases in Global Health

As part of a series in advance of AIDS 2010, the "Science Speaks" blog features an interview with U.S. Global AIDS Coordinator Eric Goosby "about his expectations for the conference, what was behind the Uganda problem with shortages of AIDS medicine, and whether The New York Times was right when it reported in May that the Ugandan drug shortfall was 'the first example … of how the war on AIDS is falling apart.'"

16 Jul 2010

An overview of AAPM annual meeting

AAPM is the premier organization in medical physics, a broadly-based scientific and professional discipline encompassing physics principles and applications in medicine and biology. Its membership includes medical physicists who specialize in research that develops cutting-edge technologies and board-certified clinical medical physicists who apply these technologies in community hospitals, clinics, and academic medical centers.

16 Jul 2010

Federal ban on use of antimicrobials in food animals will impact both animal and human health, says AVMA

The American Veterinary Medical Association (AVMA) today cautioned against federal bans on the judicious use of antimicrobials in animal agriculture.

16 Jul 2010

Lab-on-Bead technology helps researchers cut years from drug development

New research accepted by the Journal of Molecular Recognition confirms that a revolutionary technology developed at Wake Forest University will slash years off the time it takes to develop drugs - bringing vital new treatments to patients much more quickly.

16 Jul 2010

Joint statement to help patients, physicians make informed decisions about use of rosiglitazone

The Endocrine Society, American Diabetes Association and American Association of Clinical Endocrinologists issue joint statement in response to an FDA panel's recommendation to keep rosiglitazone (Avandia) on the market

16 Jul 2010

Treatment admissions for abuse of prescription pain relievers increases by over 400%: Study

The proportion of all substance abuse treatment admissions of those aged 12 and older involving abuse of prescription pain relievers rose by over 400 percent from 2.2 percent in 1998 to 9.8 percent in 2008 according to a new study be the Substance Abuse and Mental Health Services Administration (SAMHSA). This dramatic rise in the proportion of admissions associated with the abuse of these drugs occurred among nearly all segments of the population regardless of age, gender, educational level and employment status.

16 Jul 2010

Drugs News and Research

Effective AIDS treatment but poor accessibility: Report from International AIDS conference 2010

Artificial colours in food linked to cancer and behavioral disorders in children: Study

Researchers to receive $1.2M from Susan G. Komen for the Cure for breast cancer research

CCTP focuses on identifying, testing drugs for cancer stem cell treatment

Maxygen's option and licensing arrangement with Cangene expires

Ingen files patent to produce new drug insulin thermos product

NCOA adds ILS as partner to sponsor Private Label version of online screening service for senior benefits

Pain medication abuse soars

Cleveland Clinic to provide heart care in Chicago; Johns Hopkins increases primary care in D.C. area

Amgen granted FDA priority review designation for denosumab BLA

FDA can promote personalized medicine by identying gaps in laboratory operations: ACLA

Capitol Hill Watch: Obama agenda under scrutiny as lawmakers talk Medicare, budgets

94 indicted in five-state crackdown on Medicare fraud

Research findings may help identify human TOR kinase inhibitors

Recent releases in Global Health

An overview of AAPM annual meeting

Federal ban on use of antimicrobials in food animals will impact both animal and human health, says AVMA

Lab-on-Bead technology helps researchers cut years from drug development

Joint statement to help patients, physicians make informed decisions about use of rosiglitazone

Treatment admissions for abuse of prescription pain relievers increases by over 400%: Study

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News